Press release
Antifungal Drugs Market to Witness Remarkable Growth by 2027 | key players Bayer Healthcare, Sanofi-Aventis, Novartis
Antifungal Drugs Market
The Global Antifungal Drugs market accounted to US$ 10,182.3 Mn in 2018 and is expected to grow at a CAGR of 3.2% during the forecast period 2019 – 2027, to account to US$ 13,524.2 Mn by 2027.
Asia Pacific is the fastest growing geographic market and it is expected to be the fastest revenue contributor throughout the forecast period. Asia Pacific is recognized as a developing market for the pharmaceutical. The growth is driven by that countries such as China, and India which are engaged in conducting several studies.
Get Sample Copy of the Report at – https://www.theinsightpartners.com/sample/TIPRE00003745/?utm_source=OpenPR&utm_medium=10271
Strategic Insights
Organic and inorganic growth strategies were observed in global Antifungal Drugs industry. The organic strategies which were conducted more compared to the inorganic strategies for the Antifungal Drugs. For instance, in November, 2017, Merck & Co., Inc. declared that the U.S. Food and Drug Administration (FDA) approved PREVYMIS (letermovir) to be uses as once-daily tablets for oral use and injection for intravenous infusion. Thus, the organic strategy has enabled the company to grow its business in the market.
Antifungal Drugs – MARKET SEGMENTATION
Global Antifungal Drugs Market – By Infection Type
Superficial Fungal Infection
Systemic Fungal Infection
Global Antifungal Drugs Market – By Drug Type
Echinocandins
Azoles
Polyenes
Allylamines
Others
Global Antifungal Drugs Market – By Therapeutic Indication
Aspergillosis
Dermatophytosis
Candidiasis
Others
Global Antifungal Drugs Market – By Dosage Form
Drugs
Ointment
Powder
Others
By Geography
North America
U.S.
Canada
Mexico
Europe
France
Germany
UK
Spain
Italy
Asia Pacific (APAC)
China
India
Japan
Australia
South Korea
Middle East & Africa (MEA)
Saudi Arabia
South Africa
UAE
South America (SAM)
Brazil
Argentina
Company Profiles
Pfizer Inc.
Sanofi S.A.
Gilead Sciences, Inc.
Merck And Co., Inc.
Scynexis Inc.
Novartis International AG
Abbott Laboratories
Bayer AG
Glenmark Pharmaceutical
Glaxosmithkline Plc.
Growing Pharmaceutical Industry in Developing Regions
The developing nations are incredibly diverse, and the diseases and health care problems they face are somewhat variable. Thus, the solutions are different and must be made to fit local circumstances. Emerging nations represent an excellent opportunity for the pharmaceutical industry. The emerging markets are expected to be the crucial factor for offering better and lucrative growth opportunities for the market players to expand their business and geographic reach.
The treatment for the fungal infections become more straightforward due to the help of the advancement in the technologies. Also, the healthcare expenditure has created lots of opportunities for the developing nations to provide better and more services and facilities to their people. Regions like Asia, the Middle East, and Africa are investing more in the healthcare sectors.
Avail Discount on this Report at
https://www.theinsightpartners.com/sample/TIPRE00003745/?utm_source=OpenPR&utm_medium=10271
Market Insights
Increasing Incidence of Cancers, HIV, and Hospital-Acquired Infections
The incidence of fungal infections due to numerous diseases has increased over the last few decades. Furthermore, bloodstream infection incidence is bimodal, with adult people and premature babies having the maximum risk. Cancer treatment using chemotherapy and radiation causes various changes in the body as they destruct cancer cells. Among the significant difference, one is that this treatment weakens the immune system that increases the chances of getting a fungal infection.
Many fungal infections are called opportunistic infections, as they generally affect people with weak immune systems. As HIV weakens the immune system, it is more prone to have some types of fungal infections, like coccidioidomycosis, histoplasmosis, cryptococcosis, and pneumocystis pneumonia (PCP).
According to data published by J. Fungi 2017, approximately 3,000,000 cases of chronic pulmonary aspergillosis, around 223,100 cases of cryptococcal meningitis among HIV/AIDs patients. And nearly 700,000 cases of invasive candidiasis, about 250,000 cases of invasive aspergillosis, approximately 100,000 cases of disseminated histoplasmosis, more than 10,000,000 cases of fungal asthma, and around 1,000,000 cases of fungal keratitis occur per annum.
Contact Us:
Call: +1-646-491-9876
Email: sales@theinsightpartners.com
Website: www.theinsightpartners.com
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Antifungal Drugs Market to Witness Remarkable Growth by 2027 | key players Bayer Healthcare, Sanofi-Aventis, Novartis here
News-ID: 1893665 • Views: …
More Releases from The Insight Partner
3D Printing Material Market Statistics, Trends, Size, Share, Regional Analysis b …
The 3D Printing Material Market is extremely competitive and consolidated because of the existence of several established companies that are adopting different marketing strategies to increase their market share. The vendors engaged in the sector are outlined based on their geographic reach, financial performance, strategic moves, and product portfolio. The vendors are gradually widening their strategic moves, along with customer interaction.
Get Sample PDF Copy at : https://www.theinsightpartners.com/sample/TIPTE100000389/?utm_source=OpenPR&utm_medium=10768
The report profiles the…
Biochar Market Current Status by Major Key Vendors and Trends by Forecast to 203 …
Biochar Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period.
To get sample Copy of the report, along with the TOC, Statistics, and Tables please visit @
https://www.theinsightpartners.com/sample/TIPRE00009475/?utm_source=OpenPR&utm_medium=10768
The Biochar Industry is extremely competitive and consolidated because of the existence of…
Fire Safety Equipment Market Size, Share, Forecast, Growth analysis 2027
The Insight Partners, through the latest research- "Global Fire Safety Equipment Market Size Report | Industry & Analysis - Forecast Year" presents a systematic market analysis for businesses opting to enter or excel in the Fire Safety Equipment market. The research is the result of the meticulous expression of industry annotations along with evidence. The survey is enhanced further to extend detailed segmentation in the Fire Safety Equipment market. A…
Temperature Control Unit Market Expected to Reach Tremendous Growth, Industry In …
Temperature Control Unit Market study by "The Insight Partners" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years.
The report segments the global Temperature Control Unit Market based on application, type, service, technology, and region. Each chapter under this segmentation allows readers to grasp the nitty-gritty of the…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…
